文献速递产科母胎医学

产前诊断血管前置的分娩时机与不良妊娠结局:系统综述与Meta分析

Timing of birth and adverse pregnancy outcomes in cases of prenatally diagnosed vasa previa: a systematic review and meta-analysis.
PubMed 文献 · Am J Obstet Gynecol · 2022-03-10

该系统综述与Meta分析检索截至2022年1月的文献,纳入37项研究(其中14项进入定量合成),共490例新生儿,评估产前诊断血管前置在不同孕周分娩的围产结局。结果显示,新生儿并发症率从<32周的4.6%围产儿死亡等指标,逐渐降至36周时的0%围产儿死亡,37周轻度回升后38周再降;作者认为,对于其他方面无并发症的产前诊断血管前置妊娠,延长至36周分娩似乎安全且有益。

要点

  • 在490例产前诊断血管前置的新生儿中,围产儿死亡2例(0.4%),均为<32周的新生儿死亡。
  • 新生儿并发症率从<32周(围产儿死亡4.6%、呼吸窘迫91.2%)降至36周(围产儿死亡0%、呼吸窘迫5.3%)。
  • 并发症在37周轻度回升、38周再降;作者认为其他方面无并发症者延长至36周分娩似乎安全且有益。

核心结论

  • 对于其他方面无并发症的产前诊断血管前置妊娠,将妊娠延长至36周分娩似乎安全且有益。

研究设计与样本

  • 系统综述与Meta分析,检索Ovid MEDLINE、PubMed、CINAHL、Embase、Scopus和Web of Science自建库至2022年1月。
  • 纳入队列研究、病例系列和病例报告进行定性合成;共37项研究纳入分析,其中14项纳入定量合成。
  • 采用美国国立卫生研究院(National Institutes of Health)相应研究类型的质量评估工具进行质量评价,并使用随机效应模型对比例进行Meta分析。

主要发现

  • 在490例新生儿中,围产儿死亡2例(0.4%),均为<32周的新生儿死亡。
  • 从<32周至36周,围产儿死亡从4.6%降至0%,呼吸窘迫从91.2%降至5.3%,5分钟Apgar评分<7从11.4%降至0%,新生儿输血从23.3%降至2.9%,新生儿重症监护病房入住从100%降至29.2%,低出生体重从100%降至30.9%。
  • 并发症在37周轻度升高,随后在38周再次下降。

临床怎么用

  • 作者认为,对于其他方面无并发症的产前诊断血管前置妊娠,延长至36周分娩似乎安全且有益。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The ideal time for birth in pregnancies diagnosed with vasa previa remains unclear. We conducted a systematic review aiming to identify the gestational age at delivery that best balances the risks for prematurity with that of pregnancy prolongation in cases with prenatally diagnosed vasa previa. DATA SOURCES: Ovid MEDLINE, PubMed, CINAHL, Embase, Scopus, and Web of Science were searched from inception to January 2022. STUDY ELIGIBILITY CRITERIA: The intervention analyzed was delivery at various gestational ages in pregnancies prenatally diagnosed with vasa previa. Cohort studies, case series, and case reports were included in the qualitative synthesis. When summary figures could not be obtained directly from the studies for the quantitative synthesis, authors were contacted and asked to provide a breakdown of perinatal outcomes by gestational age at birth. METHODS: Study appraisal was completed using the National Institutes of Health quality assessment tool for the respective study types. Statistical analysis was performed using a random-effects meta-analysis of proportions. RESULTS: The search identified 3435 studies of which 1264 were duplicates. After screening 2171 titles and abstracts, 140 studies proceeded to the full-text screen. A total of 37 studies were included for analysis, 14 of which were included in a quantitative synthesis. Among 490 neonates, there were 2 perinatal deaths (0.4%), both of which were neonatal deaths before 32 weeks' gestation. In general, the rate of neonatal complications decreased steadily from <32 weeks' gestation (4.6% rate of perinatal death, 91.2% respiratory distress, 11.4% 5-minute Apgar score <7, 23.3% neonatal blood transfusion, 100% neonatal intensive care unit admission, and 100% low birthweight) to 36 weeks' gestation (0% perinatal death, 5.3% respiratory distress, 0% 5-minute Apgar score <7, 2.9% neonatal blood transfusion, 29.2% neonatal intensive care unit admission, and 30.9% low birthweight). Complications then increased slightly at 37 weeks' gestation before decreasing again at 38 weeks' gestation. CONCLUSION: Prolonging pregnancies until 36 weeks' gestation seems to be safe and beneficial in otherwise uncomplicated pregnancies with antenatally diagnosed vasa previa.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Mitchell SJ, Ngo G, Maurel KA, et al. Timing of birth and adverse pregnancy outcomes in cases of prenatally diagnosed vasa previa: a systematic review and meta-analysis. Am J Obstet Gynecol. 2022. PMID: 35283090. doi:10.1016/j.ajog.2022.03.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。